Development of and recovery from secondary hypogonadism in aging men: Prospective results from the EMAS

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 8, 2015, Pages 3172-3182

  Rastrelli, Giulia ^a   Carter, Emma L ^b   Ahern, Tomas ^b   Finn, Joseph D ^b   Antonio, Leen ^c   O'Neill, Terence W ^d   Bartfai, Gyorgy ^e   Casanueva, Felipe F ^f   Forti, Gianni ^a   Keevil, Brian ^g   Maggi, Mario ^a,h   Giwercman, Aleksander ^i,j   Han, Thang S ^k   Huhtaniemi, Ilpo T ^l   Kula, Krzysztof ^m   Lean, Michael E J ⁿ   Pendleton, Neil ^b   Punab, Margus ^o   Vanderschueren, Dirk ^c   Wu Prof Md, Frederick C W ^b   Pott, C ^p   Wouters, E ^p   Nilsson, M ^p   Del Mar Fernandez, M ^p   Jedrzejowska, M ^p   Tabo, H M ^p   Heredi, A ^p   Moseley, C ^p   more..

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e UNIVERSITY OF SZEGED   (Hungary)

^f HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^g Department of Clinical Biochemistry   (Italy)

^h NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

ⁱ MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^j LUND UNIVERSITY HOSPITAL   (Sweden)

^k ASHFORD AND ST PETER'S HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^l IMPERIAL COLLEGE LONDON   (United Kingdom)

^m MEDICAL UNIVERSITY OF LODZ   (Poland)

ⁿ UNIVERSITY OF GLASGOW   (United Kingdom)

^o TARTU UNIVERSITY CLINICS   (Estonia)

^p NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGING; ARTICLE; BODY MASS; CLINICAL FEATURE; CONTROLLED STUDY; CONVALESCENCE; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DISEASE PREDISPOSITION; ERECTILE DYSFUNCTION; FOLLOW UP; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; INCIDENCE; LIBIDO DISORDER; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OBESITY; PREDICTION; PRIORITY JOURNAL; WAIST CIRCUMFERENCE; WEIGHT GAIN; WEIGHT REDUCTION; CLINICAL TRIAL; COHORT ANALYSIS; COMPLICATION; HYPOGONADISM; MIDDLE AGED; MULTICENTER STUDY; PHYSIOLOGY; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

ADULT; AGED; AGING; COHORT STUDIES; FOLLOW-UP STUDIES; HUMANS; HYPOGONADISM; LIFE STYLE; MALE; MIDDLE AGED; OBESITY; RECOVERY OF FUNCTION; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; WAIST CIRCUMFERENCE; WEIGHT LOSS;

EID: 84939123662     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-1571     Document Type: Article

References (33)

1. Wu FC, Tajar A, Pye SR, et al. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab. 2008;93:2737-2745.
2. Travison TG, Araujo AB, Kupelian V, O'Donnell AB, McKinlay JB. The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. J Clin Endocrinol Metab. 2007;92:549-555.
3. Saad F, Aversa A, Isidori AM, Gooren LJ. Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review. Curr Diabetes Rev. 2012;8:131-143.
4. Camacho EM, Huhtaniemi IT, O'Neill TW, et al. Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study. Eur J Endocrinol. 2013;168:445-455.
5. Tajar A, Forti G, O'Neill TW, et al. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J Clin Endocrinol Metab. 2010;95:1810-1818.
6. Corona G, Maseroli E, Rastrelli G, et al. Characteristics of compensated hypogonadism in patients with sexual dysfunction. J Sex Med. 2014;11:1823-1834.
7. Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95:2536-2559.
8. Wu FC, Tajar A, Beynon JM, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010;363:123-135.
9. Han TS, Tajar A, O'Neill TW, et al. Impaired quality of life and sexual function in overweight and obese men: the European Male Ageing Study. Eur J Endocrinol. 2011;164:1003-1011.
10. Luppino FS, de Wit LM, Bouvy PF, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010;67:220-229.
11. Riebe D, Blissmer BJ, Greaney ML, Garber CE, Lees FD, Clark PG. The relationship between obesity, physical activity, and physical function in older adults. J Aging Health. 2009;21:1159-1178.
12. Lee DM, O'Neill TW, Pye SR, et al. The European Male Ageing Study (EMAS): design, methods and recruitment. Int J Androl. 2009;32:11-24.
13. Lee DM, Pye SR, Tajar A, et al. Cohort profile: the European Male Ageing Study. Int J Epidemiol. 2013;42:391-401.
14. Vermeulen A, Stoïca T, Verdonck L. The apparent free testosterone concentration, an index of androgenicity. J Clin Endocrinol Metab. 1971;33:759-767.
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
16. Derby CA, Zilber S, Brambilla D, Morales KH, McKinlay JB. Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: The Massachusetts Male Ageing Study. Clin Endocrinol (Oxf). 2006;65:125-131.
17. Mohr BA, Bhasin S, Link CL, O'Donnell AB, McKinlay JB. The effect of changes in adiposity on testosterone levels in older men: longitudinal results from the Massachusetts Male Aging Study. Eur J Endocrinol. 2006;155:443-452.
18. Porte D Jr, Baskin DG, Schwartz MW. Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C. elegans to humans. Diabetes. 2005;54:1264-1276.
19. Pittas AG, Joseph NA, Greenberg AS. Adipocytokines and insulin resistance. J Clin Endocrinol Metab. 2004;89:447-452.
20. Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev. 2006;27:73-100.
21. George JT, Millar RP, Anderson RA. Hypothesis: kisspeptin mediates male hypogonadism in obesity and type 2 diabetes. Neuroendocrinology. 2010;91:302-307.
22. Stokes VJ, Anderson RA, George JT. How does obesity affect fertility in men - and what are the treatment options? Clin Endocrinol (Oxf). 2015;82(5):633-638.
23. Dhindsa S, Furlanetto R, Vora M, Ghanim H, Chaudhuri A, Dandona P. Low estradiol concentrations in men with subnormal testosterone concentrations and type 2 diabetes. Diabetes Care. 2011;34:1854-1859.
24. Lindsted KD, Fraser GE, Steinkohl M, Beeson WL. Healthy volunteer effect in a cohort study: temporal resolution in the Adventist Health Study. J Clin Epidemiol. 1996;49:783-790.
25. Shi Z, Araujo AB, Martin S, O'Loughlin P, Wittert GA. Longitudinal changes in testosterone over five years in community-dwelling men. J Clin Endocrinol Metab. 2013;98:3289-3297.
26. Corona G, Rastrelli G, Monami M, et al. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. Eur J Endocrinol. 2013;168:829-843.
27. Mensah GA, Mokdad AH, Ford ES, Greenlund KJ, Croft JB. State of disparities in cardiovascular health in the United States. Circulation. 2005;111:1233-1241.
28. Hu B, Li W, Wang X, Liu L, Teo K, Yusuf S. Marital status, education, and risk of acute myocardial infarction in Mainland China: the INTER-HEART study. J Epidemiol. 2012;22:123-129.
29. McMichael AJ, McKee M, Shkolnikov V, Valkonen T. Mortality trends and setbacks: global convergence or divergence? Lancet. 2004;363:1155-1159.
30. Corona G, Isidori AM, Buvat J, et al. Testosterone supplementation and sexual function: a meta-analysis study. J Sex Med. 2014;11:1577-1592.
31. Isidori AM, Giannetta E, Greco EA, et al. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clin Endocrinol (Oxf). 2005;63:280-293.
32. Zarrouf FA, Artz S, Griffith J, Sirbu C, Kommor M. Testosterone and depression: systematic review and meta-analysis. J Psychiatr Pract. 2009;15:289-305.
33. Vermeulen A, Verdonck G. Representativeness of a single point plasma testosterone level for the long term hormonal milieu in men. J Clin Endocrinol Metab. 1992;74:939-942.